Anthony D Pomicter

6PUBLICATIONS
22CO-AUTHORS
Gene and molecular therapyAllergyMolecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 03, 2026
Personalized Molecular Monitoring of a Cryptic DIAPH1::PDGFRB Fusion in Chronic Eosinophilic Leukemia Using Droplet Digital Polymerase Chain Reaction.

|Oct 14, 2024
Clonal dynamics of aggressive systemic mastocytosis on avapritinib therapy.

Xiaomeng Huang, Anthony D Pomicter, Jonathan Ahmann

|Dec 17, 2021
Trident cold atmospheric plasma blocks three cancer survival pathways to overcome therapy resistance.

Bo Guo, Anthony D Pomicter, Francis Li

|Nov 15, 2021
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis.

Helong Zhao, Anthony D Pomicter, Anna M Eiring

|May 24, 2021
SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA.

Dongqing Yan, Anca Franzini, Anthony D Pomicter

|Sep 22, 2019
ddeeper Than Deep: Can ddPCR Predict Successful Imatinib Cessation?

Dongqing Yan, Anthony D Pomicter, Thomas O'Hare

Pageof 1

Frequent Collaborators

3 joint publications

Michael W Deininger

1 joint publications

Brayden J Halverson

1 joint publications

Shawn C Owen

1 joint publications

James E Cox